Synchronous colorectal cancers (syCRCs) are physically separated tumours that develop simultaneously. To understand how the genetic and environmental background influences the development of multiple tumours, here we conduct a comparative analysis of 20 syCRCs from 10 patients. We show that syCRCs have independent genetic origins, acquire dissimilar somatic alterations, and have different clone composition. This inter- and intratumour heterogeneity must be considered in the selection of therapy and in the monitoring of resistance. SyCRC patients show a higher occurrence of inherited damaging mutations in immune-related genes compared to patients with solitary colorectal cancer and to healthy individuals from the 1,000 Genomes Project. Moreover, they have a different composition of immune cell populations in tumour and normal mucosa, and transcriptional differences in immune-related biological processes. This suggests an environmental field effect that promotes multiple tumours likely in the background of inflammation.
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes / M. Cereda, G. Gambardella, L. Benedetti, F. Iannelli, D. Patel, G. Basso, R.F. Guerra, T.P. Mourikis, I. Puccio, S. Sinha, L. Laghi, J. Spencer, M. Rodriguez-Justo, F.D. Ciccarelli. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - 7:1(2016 Jul 05), pp. 12072.1-12072.12. [10.1038/ncomms12072]
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes
M. CeredaPrimo
;L. Benedetti;F. Iannelli;
2016
Abstract
Synchronous colorectal cancers (syCRCs) are physically separated tumours that develop simultaneously. To understand how the genetic and environmental background influences the development of multiple tumours, here we conduct a comparative analysis of 20 syCRCs from 10 patients. We show that syCRCs have independent genetic origins, acquire dissimilar somatic alterations, and have different clone composition. This inter- and intratumour heterogeneity must be considered in the selection of therapy and in the monitoring of resistance. SyCRC patients show a higher occurrence of inherited damaging mutations in immune-related genes compared to patients with solitary colorectal cancer and to healthy individuals from the 1,000 Genomes Project. Moreover, they have a different composition of immune cell populations in tumour and normal mucosa, and transcriptional differences in immune-related biological processes. This suggests an environmental field effect that promotes multiple tumours likely in the background of inflammation.File | Dimensione | Formato | |
---|---|---|---|
04_Nat_Commun_2016.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
961.75 kB
Formato
Adobe PDF
|
961.75 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.